The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Nasal Polyposis: From Cytokines to Growth
Abstract
Nasal polyposis (NP) is a chronic inflammatory condition that is mostly characterized by an infiltration of eosinophils. How this eosinophilic inflammation leads to polyp formation remains largely unclear. In order to identify the most important factors in polyp growth, first we report the histologic features of two early stage manifestations of eosinophilic nasal polyps compared to their surrounding normal mucosa and mature polyps from the same patients. Histomorphologic analysis of these early stage manifestations of NP showed the presence of eosinophils, forming a subepithelial cap over a pseudocyst area that was filled with albumin. In mature NP, a large pseudocyst area containing albumin was surrounded by subepithelial eosinophilia. Second, in an approach to quantify and to study possible relations between eosinophilic inflammation and changes in extracellular tissue components we measured interleukin-5 (IL-5), eotaxin, eosinophil cationic protein (ECP), leukotrienes (LTC4/D4/E4), transforming growth factor-β 1 (TGF-β 1), fibronectin, hyaluronic acid, and albumin in nasal tissue homogenates of 31 subjects. Nasal polyp samples (n = 16) were obtained during routine endonasal sinus surgery, whereas control non-polyp samples (n = 15) from subjects with (6) and without (9) allergic rhinitis were obtained from the inferior turbinate during septum surgery. In the group of polyp patients 11 received no treatment, whereas 5 were treated with oral glucocorticoids (GCS) within 4 weeks before surgery. IL-5 was measurable in 8 of 11 untreated NP, whereas IL-5 could not be detected in all 15 controls nor in 4 of 5 oral corticoid-treated polyps. The comparison between the untreated polyp group and controls showed significantly higher concentrations of IL-5, eotaxin, ECP, and albumin in polyp supernatants, whereas TGF-β 1 was significantly lower. In the oral GCS-treated group, ECP and albumin were significantly reduced compared to untreated nasal polyps. The same tendency, but not reaching significance, was seen for eotaxin and fibronectin, while no difference was found for LTC4/D4/E4 and hyaluronic acid between the groups. Our observations suggest a deposition of albumin (and possibly other plasma proteins) and extracellular matrix proteins, which may be regulated by the subepithelial eosinophilic inflammation, as a possible pathogenic principle of polyp formation and growth. IL-5 and eotaxin are found to be key factors for eosinophilic accumulation and activation in NP. Oral corticoid treatment may lead to the shrinkage of NP by downregulation of the eosinophilic inflammation and reduction of the extravasation and deposition of albumin in NP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eosinophil-associated TGF- β 1 mRNA Expression and Airways Fibrosis in Bronchial Asthma
Minshall, E. M., Leung, D. Y. M., Martin, R. J., Song, Y. L., Cameron, L., Ernst, P., & Hamid, Q. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.17.3.2733 · Cited by 636
Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia
Simon, H. U., Yousefi, S., Schranz, C., Schapowal, A., Bachert, C., & Blaser, K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3902 · Cited by 468
Self-citationYing, S., Robinson, D. S., Meng, Q., Rottman, J., Kennedy, R., Ringler, D. J., Mackay, C. R., Daugherty, B. L., Springer, M. S., Durham, S. R., et al. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271252 · Cited by 418
IL-5 synthesis is upregulated in human nasal polyp tissue
Bachert, C., Wagenmann, M., Hauser, U., & Rudack, C. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)80019-x · Cited by 366
Self-citationRelationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice.
Mould, A. W., Matthaei, K. I., Young, I. G., & Foster, P. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119234 · Cited by 343
Settipane, G. A. (1996) · Allergy and Asthma Proceedings · doi:10.2500/108854196778662246 · Cited by 234
Ohno, I., Lea, R. G., Flanders, K. C., Clark, D. A., Banwatt, D., Dolovich, J., Denburg, J., Harley, C. B., Gauldie, J., & Jordana, M. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115764 · Cited by 223
Pearlman, A. N., Chandra, R. K., Conley, D. B., & Kern, R. C. (2010) · Nasal Polyposis · doi:10.1007/978-3-642-11412-0_2 · Cited by 223
Levi-Schaffer, F., Garbuzenko, E., Rubin, A., Reich, R., Pickholz, D., Gillery, P., Emonard, H., Nagler, A., & Maquart, F. A. X. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9660 · Cited by 206
The role of cytokines in infectious sinusitis and nasal polyposis
Bachert, C., Wagenmann, M., Rudack, C., Höpken, K., Hiltebrandt, M., Wang, D., & van Cauwenberge, P. (1998) · Allergy · doi:10.1111/j.1398-9995.1998.tb03767.x · Cited by 169
Self-citationAlam, R., Forsythe, P., Stafford, S. J., & Fukuda, Y. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.3.1041 · Cited by 160
Effect of Fluticasone in Severe Polyposis
Lund, V. J., Flood, J., Sykes, A. P., & Richards, D. H. (1998) · Archives of Otolaryngology–Head & Neck Surgery · doi:10.1001/archotol.124.5.513 · Cited by 159
Lildholdt, T., Rundcrantz, H., Bende, M., & Larsen, K. (1997) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1997.01900060037006 · Cited by 149
Dibbert, B., Daigle, I., Braun, D., Schranz, C., Weber, M., Blaser, K., Zangemeister‐Wittke, U., Akbar, A. N., & Simon, H. (1998) · Blood · doi:10.1182/blood.v92.3.778 · Cited by 146
Are nasal polyps an allergic phenomenon?
Caplin, I., Jt, H., & Spahn, J. (1971) · PubMed · Cited by 141
Elovic, A., Wong, D. T., Weller, P. F., Matossian, K., & Galli, S. J. (1994) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(94)90379-4 · Cited by 128
Results of oral steroid treatment in nasal polyposis.
Camp, C. V., & Clement, P. A. R. (1994) · PubMed · Cited by 124
Nasal Polyps: Epidemiology, Pathology, Immunology, and Treatment
Settipane, G. A. (1987) · American Journal of Rhinology · doi:10.2500/105065887781693420 · Cited by 119
Fluticasone Propionate Aqueous Nasal Spray in the Treatment of Nasal Polyposis
Holmberg, K., Júlíusson, S., Balder, B., Smith, D., Richards, D. H., & Karlsson, G. (1997) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)63180-8 · Cited by 106
The effect of budesonide (Rhinocort�) in the treatment of small and medium-sized nasal polyps
Johansen, L. V., Illum, P., KRISTENSEN, S., Winther, L. K., PETERSEN, S. V., & Synnerstad, B. (1993) · Clinical Otolaryngology · doi:10.1111/j.1365-2273.1993.tb00628.x · Cited by 105
Nasal polyposis : an inflammatory disease and its treatment
Mygind, N., & Lildholdt, T. (1997) · Munksgaard eBooks · Cited by 103
Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps
Beck, L. A., Stellato, C., Beall, L. D., Schall, T. J., Leopold, D. A., Bickel, C., Baroody, F. M., Bochner, B. S., & Schleimer, R. P. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70126-4 · Cited by 102
Tos, M., Svendstrup, F., Arndal, H., Ørntoft, S., Jakobsen, J., Borum, P., Schrewelius, C., Larsen, P. L., Clement, F., Barfoed, C., et al. (1998) · American Journal of Rhinology · doi:10.2500/105065898781390217 · Cited by 101
Interleukin-5 Production by Human Airway Epithelial Cells
Salvi, S., Semper, A. E., Blomberg, A., Holloway, J. W., Jaffar, Z. H., Papi, A. A., Teran, L. M., Polosa, R., Kelly, F., Sandström, T., et al. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.5.3463 · Cited by 94
Wang, Q. P., Escudier, E., Roudot‐Thoraval, F., Samad, I. A. A., Peynegre, R., & Coste, A. (1997) · The Laryngoscope · doi:10.1097/00005537-199707000-00018 · Cited by 90
Hamilos, D. L., Thawley, S. E., Kramper, M. A., et al. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70529-4 · Cited by 87
Jahnsen, F. L., Haye, R., Gran, E., Brandtzæg, P., & Johansen, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1545 · Cited by 86
A double-blind comparison of intranasal budesonide with placebo for nasal polyposis
Ruhno, J. W., Andersson, B., Denburg, J. A., Anderson, M. H., Hitch, D., Lapp, P., Vanzieleghem, M. A., & Dolovich, J. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(05)80158-7 · Cited by 82
Nasal Polyp Inflammation. Effect of Topical Nasal Steroid
Kanai, N., Denburg, J. A., Jordana, M., & Dolovich, J. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.4.7921442 · Cited by 70
Mullol, J., Xaubet, A., Lopez, E., Roca‐Ferrer, J., & Picado, C. (1995) · Thorax · doi:10.1136/thx.50.3.270 · Cited by 67
Expression of the Transforming Growth Factor β Isoforms in Inflammatory Cells of Nasal Polyps
Coste, A., Lefaucheur, J., Wang, Q.-P., Lesprit, E., Poron, F., Peynegre, R., & Escudier, E. (1998) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.124.12.1361 · Cited by 59
Nasal Polyps Treatment: Medical Management
Mygind, N., & Lildholdt, T. (1996) · Allergy and Asthma Proceedings · doi:10.2500/108854196778662228 · Cited by 51
Human eosinophils prefernentially surivive on tissue fibronectin compared with plasama fibronection
Walsh, G. M., Symon, F. A., & Wardlaw, A. J. (1995) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1995.tb03260.x · Cited by 43
The Role of Interleukin 5 in the Production and Function of Eosinophils
Tavernier, J. H., Plaetinck, G., Guisez, Y., der Heyden, J. V., KIPS, J. C., Peleman, R. A., & Devos, R. (1996) · Blood cell biochemistry · doi:10.1007/978-0-585-31728-1_13 · Cited by 24
Biewenga, J., Stoop, A. E., van der Heijdena, H. A. M. D., van der Baan, S., & van Kamp, G. J. (1995) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(95)70052-8 · Cited by 19
Mast cell ultrastructure in the inferior turbinate and stroma of nasal polyps
Drake‐Lee, A., & Price, J. (1997) · The Journal of Laryngology & Otology · doi:10.1017/s0022215100137260 · Cited by 19
Drake‐Lee, A., Chevreton, E., & Lowe, D. (1988) · The Journal of Laryngology & Otology · doi:10.1017/s0022215100107431 · Cited by 12
Cited by
Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers
Tomassen, P., Vandeplas, G., Van Zele, T., Cardell, L.-O., Arebro, J., Olze, H., Förster-Ruhrmann, U., Kowalski, M. L., Olszewska-Ziąber, A., Holtappels, G., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.12.1324 · Cited by 1,162
Self-citationRhinosinusitis: Establishing definitions for clinical research and patient care
Meltzer, E. O., Hamilos, D. L., Hadley, J. A., Lanza, D. C., Marple, B. F., Nicklas, R. A., Bachert, C., Baraniuk, J., Baroody, F. M., Benninger, M. S., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.09.029 · Cited by 854
Self-citationDifferentiation of chronic sinus diseases by measurement of inflammatory mediators
Van Zele, T., Claeys, S., Gevaert, P., Van Maele, G., Holtappels, G., Van Cauwenberge, P., & Bachert, C. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01225.x · Cited by 774
Self-citationTotal and specific IgE in nasal polyps is related to local eosinophilic inflammation
Bachert, C., Gevaert, P., Holtappels, G., Johansson, S. G. O., & van Cauwenberge, P. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.112374 · Cited by 702
Self-citationMepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis
Gevaert, P., Van Bruaene, N., Cattaert, T., Van Steen, K., Van Zele, T., Acke, F., De Ruyck, N., Blomme, K., Sousa, A. R., Marshall, R. P., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.07.056 · Cited by 629
Self-citation
Metadata
- Authors
- Bachert, C., Gevaert, P., Holtappels, G., Cuvelier, C., & Van Cauwenberge, P.
- Venue
- American Journal of Rhinology
- Publisher
- SAGE Publications
- Published
- 2000-09
- Volume
- 14
- Issue
- 5
- Pages
- 279-290
- ISSN
- 1050-6586 (ISSN-L)
- 1539-6290
- OpenAlex
- W2074897148
- Cited by
- 318
- References
- 37
- FWCI
- 9.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.